Postoperative Complications
Conditions
Keywords
bariatric surgery, laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, Morbid obesity, Weight loss, Metabolic control, Metabolic syndrome, Complication risk
Brief summary
This study compared differences in weight loss, comorbidity resolution and complications and reoperations between a recently established sleeve gastrectomy (SG) and prior laparoscopic Rox-en-Y gastric bypass (RYGB).
Detailed description
This retrospective study with prospectively collected registry data presents results from establishment of SG as standard procedure for morbid obesity. Our first 368 patients operated with a SG were compared to 647 patients previously operated with a (RYGB. Perioperative data and results up to 2 years postoperatively regarding weight control, metabolic control as well as complications/reoperations necessary were registered. In summary, a RYGB was associated with a longer operation time and higher rates of late complications and reoperations. Diabetes resolution was similar in both groups but patients with a RYGB had greater weight loss and significant improvement in hypertension and dyslipidemias.
Interventions
PROCEDURESG or a RYGB
operation type differed between a partial gastrectomy (SG)or a combined restrictive/malabsorptive
Sponsors
Umeå University
Study design
Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No
Inclusion criteria
* Patients with either a BMI 35 or higher with comorbidity, or patients with a BMI of 40 or more without known comorbidity associated, undergoing a primary laparoscopic bariatric surgery in Sundsvall,Sweden 2010-01-01 to 2018-06-10.
Exclusion criteria
* All other patients undergoing a bariatric surgery during this time frame
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Weight loss | after 6 weeks | weight and height will be combined to report various measurements of BMI in kg/m\^2 |
| Changes in Diabetes | after 1 year | measured as fasting plasma glucose and/or Hemoglobin A1c |
| Changes in Hypertension | after 1 year | measured as Systolic- and Diastolic Blood Pressure |
| Changes in hypertriglyceridemia (plasma-level >1.7 mmol/l) | after 1 year | measured as hypertriglyceridaemia (plasma-level \>1.7 mmol/l) |
| Changes in Hypercholesterolemia (LDL-C > 3.0 mmol/L and/or HDL-C < 1.0 mmol/L). | after 1 years | Measured as Hypercholesterolemia (Plasma concentration of LDL \>3.0 mmol/L and/or of HDL \< 1.0 mmol/L). |
| Duration of surgery | From the start of the operation until completion, in average 62 minutes | Operation time in minutes |
| Duration of hospital stay | From time of operation until discharge, in average 1.7 days | Duration of hospital stay in days |
| Early complications | At six weeks | Complications occurred until six weeks from operation |
| Early reoperations | At six weeks | Reoperations occurred until six weeks from operation |
| Late complications | From six weeks until 2 years from operation | Complications occurred from six weeks until 2 years from operation |
| Late reoperations | From six weeks until 2 years from operation | Reoperations occurred from six weeks until 2 years from operation |
Countries
Sweden
Outcome results
None listed